Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Conference Recordings
…possible treatment approaches for the most common types of CMT. Genetic counselor Tanya Bardakjian shares information on the genetic mutations associated with CMT, genetic testing, inheritance patterns, and much more….
Terms & Conditions
…or treatment. CMTA does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the…
2021_Summer_CMTA_Report
Heather Hawk Frank, Cleveland, OH CMTA Branch Leader
…the CMTA. Although Heather was excited to discover a group working to raise awareness and find a treatment for CMT, she was disappointed that there were no support groups in…
Gilles Bouchard Takes Helm of CMTA Board
…that while he is “excited and delighted” with the progress made by the CMTA’s STAR research program, there’s still much work to be done before a first drug treatment for…
Invitae Announces Major Expansion of Its Neurology Test Offerings
…better treatments and improve healthcare for everyone.” Invitae’s latest expansion of its test offering is based on the latest research findings in genetics across various panels. For example, three peer-reviewed…
New Mobile App Simplifies Sign-Up for Patient Registry
…treatment, can be found at www.cmtausa.org/research/cmt-clinical-trial-registry/. Signing up for the registry gives the user access to a list of current open studies and contact information for signing up for them….
The CMTA Announces the Funding of a New Research Study for CMT2A
…(CMT2A). The aim of the study is to develop a night-time breathing treatment similar to CPAP (for sleep apnea) with the goal of helping respiratory issues and improving breathing for…
Lower Extremity Review
Lower Extremity Review is a monthly magazine that informs healthcare practitioners on current developments in the diagnosis, treatment, and prevention of injuries and conditions affecting the lower extremities, including CMT….
CMTA Staff
Dr. Suzanne (Sue) Bruhn | she/her Chief Executive Officer Sue has dedicated her career to patient-focused drug development for the treatment of rare diseases. She’s had a long career in…